| Issue | Title | |
| Vol 2100, No 9999 (2100) | 2019_1 | Abstract pdf pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_10 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_11 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_12 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2019_2 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_3 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_4 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_5 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_6 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_7 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_8 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2019_9 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2020_10 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2020_11 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2020_12 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2020_2 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2020_3 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2020_4 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2020_5 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2020_6 | Abstract pdf |
| Antony Charles Allen | ||
| Vol 2100, No 9999 (2100) | 2020_7 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2020_8 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2020_9 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2021_1 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2021_10 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2021_11 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2021_12 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2021_2 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2021_3 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2021_4 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2021_5 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2021_7 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2021_8 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2021_9 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_1 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_11 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2022_12 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2022_2 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_3 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_4 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_5 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_6 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_7 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_8 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2022_9 | Abstract pdf |
| Antony Allen | ||
| Vol 2100, No 9999 (2100) | 2023_1 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_10 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_11 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_12 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_2 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_3 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_4 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_5 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_6 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_7 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_8 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2023_9 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_1 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_10 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_11 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_12 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_2 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_3 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_4 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_5 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_6 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_7 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_8 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2024_9 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2025_1 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2025_2 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2100, No 9999 (2100) | 2025_3 | Abstract pdf |
| Taskin Ahmed | ||
| Vol 2006, No 78 (2006) | 3M Divests its Pharmaceutical Business | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 65 (2005) | 7TM Pharma AS | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 76 (2006) | A Hostile Genzyme and AnorMED Unrest: Changing Times for the Biotech Industry | Abstract pdf |
| Business Review Editor | ||
| Vol 2007, No 79 (2007) | A Partnership between Little and Large | Abstract pdf |
| Business Review Editor | ||
| Vol 2013, No 2 (2013) | A Review of Deal Making in 2012 | Abstract |
| Heather Cartwright | ||
| Vol 2007, No 83 (2007) | A Shot in the Arm for Oxford BioMedica | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 63 (2005) | Abatacept | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 49 (2004) | Abbott Acquires Remaining Rights to Trandolapril from Aventis | Abstract pdf |
| Business Review Editor | ||
| Vol 2009, No 11 (2009) | Abbott Acquires Rights for PanGenetics’ Analgesic | Abstract |
| Taskin Ahmed | ||
| Vol 2002, No 30 (2002) | Abbott and Domantis Collaborate on Antibody Therapeutics | Abstract pdf |
| Business Review Editor | ||
| Vol 2010, No 2 (2010) | Abbott and Pierre Fabre Target Cancer in Antibody Pact | Abstract |
| Taskin Ahmed | ||
| Vol 2011, No 4 (2011) | Abbott Becomes Seattle Genetics’ Latest Antibody-Drug Conjugate Collaborator | Abstract |
| Heather Cartwright | ||
| Vol 2004, No 45 (2004) | Abbott Boosts Diabetes Unit through Acquisition of TheraSense | Abstract pdf |
| Business Review Editor | ||
| Vol 2010, No 3 (2010) | Abbott Buys Facet Biotech to Enhance Pipeline | Abstract |
| PharmaDeals Analyst | ||
| Vol 2009, No 8 (2009) | Abbott Buys Stake in Genetics Testing Company | Abstract |
| Taskin Ahmed | ||
| Vol 2010, No 5 (2010) | Abbott Enters Into Deals with Piramal and Zydus Cadila to Accelerate Growth in Emerging Markets | Abstract |
| Debbie Tranter | ||
| Vol 2003, No 41 (2003) | Abbott Laboratories Buys Medical Devices Company, then Sells Diagnostic Products | Abstract pdf |
| Business Review Editor | ||
| Vol 2010, No 8 (2010) | Abbott Pays Top Dollar to License Phase II Chronic Kidney Disease Therapy from Reata Pharmaceuticals | Abstract |
| Heather Cartwright | ||
| Vol 2009, No 10 (2009) | Abbott Sees Emerging Markets Growth with Solvay Buyout | Abstract |
| Taskin Ahmed | ||
| Vol 2014, No 9 (2014) | Abbott Sells Developed Markets Branded Generics Business to Mylan in Spinversion | Abstract |
| Heather Cartwright | ||
| Vol 2005, No 59 (2005) | Abbott Takes First Pick at BioCurex | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 78 (2006) | Abbott Takes its Speciality Pharma Pick | Abstract pdf |
| Business Review Editor | ||
| Vol 2014, No 6 (2014) | Abbott Targets Growth in Emerging Markets with CFR Pharmaceuticals Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2004, No 44 (2004) | Abbott to Acquire Diagnostics Manufacturer for US$392 M | Abstract pdf |
| Business Review Editor | ||
| Vol 2012, No 5 (2012) | Abbott to Acquire Global Rights to Action Pharma’s Phase II Acute Kidney Injury Drug | Abstract |
| Heather Cartwright | ||
| Vol 2011, No 6 (2011) | Abbott to Develop and Commercialise Biotest’s BT-061 for Autoimmune Diseases | Abstract |
| Heather Cartwright | ||
| Vol 2002, No 27 (2002) | Abbott to Distribute Cholestech Glucose Monitoring System | Abstract |
| Business Review Editor | ||
| Vol 2002, No 24 (2002) | Abbott to take full control of Hokuriku Seiyaku | Abstract pdf |
| Business Review Editor | ||
| 201 - 300 of 2581 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |